UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser Read More
UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service Read More
UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks Read More
UK TRADING UPDATE SUMMARY: New Trend Lifestyle Sees Extended Turmoil Read More
Hutchison China Gets US FDA Fast Track Status For Surufatinib Read More
Hutchison China Sees Loss Widen But Lays "Foundations" In 2019 Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
Hutchison China Prices USD110 Million American Depositary Share Offer Read More
Hutchison China Plans USD110 Million American Depositary Share Offer Read More
Hutchinson China Reports Early Success Of Surufatinib Phase III Study Read More
Hutchison China Starts Phase II Study For Cancer Treatment In China Read More
Hutchison China Hails "Positive Step" For Cancer Treatment In China Read More
Hutchison China MediTech's Cancer Treatment Joins Key China State List Read More
Hutchison China MediTech Gets Orphan Designation For Surufatinib Read More
CORRECT (Nov 11): Hutchison's Surufatinib Gets Acceptance For Review Read More
Hutchison's Surufatinib Gets New Drug Application Approval In China Read More
Hutchison China Expands Tumour Treatment Collaboration With Innovent Read More
WINNERS & LOSERS SUMMARY: Astra Rises On Fasenra Approval In US Read More
Hutchison China Doses First Patient In HMPL-523 Lymphoma Study Read More
(Alliance News) - Hutchison China MediTech Ltd said Tuesday it has started its phase 1/1b study of small molecule inhibitor HMPL-689 in patients with advanced relapsed or refractory in the firm at Read More
